Navigating the Regulatory Landscape: 505(B)(2) Pathway for Generic Drug Development
In the realm of generic drug development, navigating the regulatory landscape can be complex and challenging. However, the 505(b)(2) pathway offers a unique route that streamlines the approval process for certain generic drugs, providing opportunities for innovation and market entry